Finally, an anti-CD20/anti-CD3 bispecific antibody targeted lymphoma and cytotoxic T-cells, showed high killing capacity both in vivo and in vitro, even with very low cell surface expression of CD20; anti-CD20 alone was unable to cause significant cell death (46). The gene discussed is MS4A1; the disease is lymphoma.